Rigel Pharmaceuticals (RIGL) Shares Outstanding (Weighted Average) (2010 - 2026)

Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $18.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 3.39% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at $18.4 million (up 3.39% YoY), while the FY2025 annual figure was $18.0 million, up 2.32% from the prior year.
• Shares Outstanding (Weighted Average) was $18.4 million for Q1 2026 at Rigel Pharmaceuticals, up from $18.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $173.6 million in Q1 2023 to a low of $17.0 million in Q4 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $54.1 million across 5 years, with a median of $17.8 million in 2025.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) plunged 90.0% in 2022, then grew 3.39% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $17.0 million in 2022, then grew by 2.06% to $17.4 million in 2023, then climbed by 1.02% to $17.6 million in 2024, then rose by 2.32% to $18.0 million in 2025, then rose by 2.36% to $18.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $18.4 million (Q1 2026), $18.0 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.